Ischemic heart disease in women: Facts and wishful thinking

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1727-1730

  Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; VERAPAMIL;

ANGINA PECTORIS; BLOOD PRESSURE MONITORING; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DATA ANALYSIS; DECISION MAKING; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FUTUROLOGY; HEALTH CARE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITAL PATIENT; HUMAN; IMAGING SYSTEM; ISCHEMIC HEART DISEASE; MEDICAL EXAMINATION; OUTCOMES RESEARCH; OUTPATIENT; PATIENT CARE; POPULATION RISK; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STRATIFICATION;

FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; SEX FACTORS; TREATMENT OUTCOME; UNITED STATES; WOMEN'S HEALTH;

EID: 2442491095     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.04.012     Document Type: Conference Paper

References (10)

1. American Heart Association. 2004, Statistical Fact Sheet: Populations. Available at: http://www.americanheart.org.
2. Netter FH. The CIBA collection of medical illustrations. Heart 1969;5:1708.
3. Spertus JA, Jones P, McDonell M, Fan V, Fihn SD. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 2002;106:43-9.
4. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
5. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al., the INVEST Investigators. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290:2805-16.
6. Sharaf BL, Shaw L, Johnson BD, et al. Any measurable coronary artery disease identified in women presenting with ischemic chest pain is associated with an adverse outcome: findings from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study angiographic core laboratory (abstr). J Am Coll Cardiol 2004;43 Suppl A:292A.
7. Shaw LJ, Sharaf BL, Johnson BD, et al., the WISE Study Group. Healthcare costs for cardiovascular disease in women with and without obstructive coronary disease; results from the National Institutes of Health-National Heart, Lung, and Blood Institutes-sponsored Women's Ischemia Syndrome Evaluation (WISE) (abstr). J Am Coll Cardiol 2004;43 Suppl A:422A.
8. von Mering GO, Arant CB, Wessel TR, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:722-5.
9. Doyle M, Pohost GM, Kortright E, et al. In women with symptoms of ischemic heart disease, global and regional myocardial perfusion status by magnetic resonance imaging better assigns risk: results from the results from the National Heart, Lung, and Blood Institutes-sponsored Women's Ischemia Syndrome Evaluation (WISE) (abstr). J Am Coll Cardiol 2004:43 Suppl A:266A.
10. Arant CB, Wessel TR, Olson MB, et al., the WISE Investigators. Serum inflammatory markers correlate with hemoglobin levels in women undergoing evaluation for suspected ischemia: results from the National Heart, Lung, and Blood Institute WISE study (abstr). J Am Coll Cardiol 2004;43 Suppl A:515A.